Paralyzed Man Moves Arm with Neuroprosthetic

Two chips implanted in a quadriplegic patient’s motor cortex and 36 electrodes in his right arm allow the man to control the movement of his right arm and hand.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

SCREEN GRAB, YOUTUBEBill Kochevar, 56, has regained some control over his right arm and hand, 10 years after becoming quadriplegic following a bike accident. This partial reversal of his paralysis is thanks to technology that allows Kochevar, with the help of two recording chips in his motor cortex and 36 electrodes in his right arm, to control a mechanized harness on which he rests his arm using only his thoughts, according to a study published this week (March 28) in The Lancet.

“I was completely amazed,” Kochevar told MIT Technology Review. In a lab at Case Western Reserve University in Cleveland, Ohio, he sipped from a straw and fed himself for the first time in a decade. “I thought about moving my arm and I could move it,” he told NPR’s Shots.

The neuroprosthetic device is not the first to restore voluntary movement to paralyzed patients. Last April, Ian Burkhart, who was paralyzed in a diving accident in 2012, made headlines after he regained control of his hand and arm using an electrode array implanted in the part of his motor cortex that controls hand movements and a sleeve of 130 electrodes worn on his forearm.

Neuroprosthetics take advantage of the motor commands that normally trigger the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies